Robert DeSimone

Assistant Professor

Weill Cornell Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Robert DeSimone is an Assistant Professor at Weill Cornell Medicine in the United States. His research focuses on transfusion medicine, including the evaluation of pathogen-reduced blood products, the accuracy of antibody titer testing, and the epidemiology of platelet transfusions in pediatric populations. Recent publications highlight his work on transfusion practices and the utilization of blood products in various clinical settings.

Articles (17)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (15)

Michelle Zeller

McMaster University

CANADA

Robert DeSimone

Research Interests

Explore related searches

Contact this professor

About

Articles (17)

Transfusion service staff and anesthesiologists prefer pathogen-reduced cryoprecipitate over conventional cryoprecipitated antihemophilic factor.

Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): study protocol for a single center, prospective, cluster randomized trial.

Blood utilization in liver transplantation (BUILT): A multidisciplinary survey of transfusion practices

Associations of donor, component, and recipient factors on hemoglobin increments following red blood cell transfusion in very low birth weight infants

Antibody Titers in Transfusion Medicine: A Critical Reevaluation of Testing Accuracy, Reliability, and Clinical Use.

Epidemiology of Platelet Transfusions in Hospitalized Children: A Pediatric Hospital Information System Database Study.

Visualization dashboard for blood product inventory management.

Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial (Nature Medicine, (2021), 27, 11, (2012-2024), 10.1038/s41591-021-01488-2)

Therapeutic plasma exchange practices in immune thrombocytopenia related hospitalizations: Results from a nationally representative sample.

Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial.

Profiling of immune dysfunction in COVID-19 patients allows early prediction of disease progression.

Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve.

Blood stewardship: Conservation and supply of blood components during the SARS-CoV-2 pandemic.

Flat line in the blood bank: code H (hyperfibrinolysis)?

Thawed solvent/detergent-treated plasma demonstrates comparable clinical efficacy to thawed plasma.

Additive effects of blood donor smoking and gamma irradiation on outcome measures of red blood cell transfusion.

Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.

Collaborators (15)

Michelle Zeller

Jeanne E. Hendrickson

Ruchika Goel

Charles Vorkas

Ljiljana Vasovic

Ravi Patel

Kohta Saito

Philip Berardi

mirella salvatore

Aaron S. Hess

Karen Doucette

Paul Simonson

Tamir Kanias

Kenichi Tanaka

Ayana Morales

Make your next move.